Evidence map›Paper›PMID 25319703›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice.

Johanna Knoferle, Seo Yeon Yoon, David Walker, Laura Leung, Anna K Gillespie, Leslie M Tong, Nga Bien-Ly, Yadong Huang

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. APOE4 disrupts the central dogma by arresting neuronal proteome dynamics.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Stem Cell Interventions in the Treatment of Alzheimer's Disease.Current stem cell research & therapy · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Johanna KnoferleGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology and.
Seo Yeon YoonGladstone Institute of Neurological Disease, San Francisco, California 94158.
David WalkerGladstone Institute of Neurological Disease, San Francisco, California 94158.ORCID http://orcid.org/0000-0003-3882-9829
Laura LeungGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology and.
Anna K GillespieGladstone Institute of Neurological Disease, San Francisco, California 94158, Biomedical Science Program, University of California, San Francisco, California 94143.
Leslie M TongGladstone Institute of Neurological Disease, San Francisco, California 94158, Biomedical Science Program, University of California, San Francisco, California 94143.
Nga Bien-LyGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology and.
Yadong HuangGladstone Institute of Neurological Disease, San Francisco, California 94158, Department of Neurology and Biomedical Science Program, University of California, San Francisco, California 94143, Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, and Department of Pathology, University of California, San Francisco, California 94143 yhuang@gladstone.ucsf.edu.
Gladstone Institutes · US

Funding

Tissue Culture CoreP01AG022074 · NIA · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2003 to 2012
$27.0M
PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
Behavioral CoreP30NS065780 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI MUCKE, LENNART · 2011 to 2015
$4.0M
Optogenetic Study of ApoE4-Related Alzheimers DiseaseRF1AG047655 · NIA · J. DAVID GLADSTONE INSTITUTES · PI HUANG, YADONG, KREITZER, ANATOL · 2014 to 2014
$2.1M
NIA NIH HHS 1RF1AG047655NIA NIH HHS P01 AG022074NIA NIH HHS P01AG022074NIA NIH HHS RF1 AG047655NICHD NIH HHS T32 HD007470NINDS NIH HHS P30 NS065780NINDS NIH HHS P30NS065780
6 · The paper itself

Abstract

Apolipoprotein (apo) E4 is expressed in many types of brain cells, is associated with age-dependent decline of learning and memory in humans, and is the major genetic risk factor for AD. To determine whether the detrimental effects of apoE4 depend on its cellular sources, we generated human apoE knock-in mouse models in which the human APOE gene is conditionally deleted in astrocytes, neurons, or GABAergic interneurons. Here we report that deletion of apoE4 in astrocytes does not protect aged mice from apoE4-induced GABAergic interneuron loss and learning and memory deficits. In contrast, deletion of apoE4 in neurons does protect aged mice from both deficits. Furthermore, deletion of apoE4 in GABAergic interneurons is sufficient to gain similar protection. This study demonstrates a detrimental effect of endogenously produced apoE4 on GABAergic interneurons that leads to learning and memory deficits in mice and provides a novel target for drug development for AD related to apoE4.

Indexed as

AnimalsApolipoprotein E4FemaleGABAergic NeuronsHumansInterneuronsLearningMemory DisordersMiceMice, TransgenicApolipoprotein E4apoEastrocyteconditional knock-out miceGABAergic interneuronlearning and memory

Identifiers

PMID25319703
PMCPMC4198545
OpenAlexW2119616605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.